Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Why it may be time to rethink AFib treatments | New data on COVID-related myocarditis
Friday, November 11, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Treating AFib early with cryoablation reduces risk of disease progression, repeat hospitalization

“The evidence shows increasingly that it’s time to rethink how we approach the treatment of AFib,” one researcher said.

READ MORE >
Medtronic’s Arctic Front cryoballoon catheters
Share on Twitter Share on Facebook Share on Linkedin

Treating AFib early with cryoablation reduces risk of disease progression, repeat hospitalization

Share on Twitter Share on Facebook Share on Linkedin
Medtronic’s Arctic Front cryoballoon catheters
“The evidence shows increasingly that it’s time to rethink how we approach the treatment of AFib,” one researcher said.
READ MORE >

COVID-related myocarditis linked to significantly worse outcomes than non-COVID cases

The new study, published in Current Problems in Cardiology, included data from nearly 18,000 adult patients. 

READ MORE >
patient_exam_cardiology_covid_dr_cowan_beaumont.jpeg
Share on Twitter Share on Facebook Share on Linkedin

COVID-related myocarditis linked to significantly worse outcomes than non-COVID cases

Share on Twitter Share on Facebook Share on Linkedin
patient_exam_cardiology_covid_dr_cowan_beaumont.jpeg
The new study, published in Current Problems in Cardiology, included data from nearly 18,000 adult patients. 
READ MORE >

Featured Articles

VIDEO: ACC president says Medicare cuts should be a call to action across healthcare

American College of Cardiology President Edward Fry, MD, spoke about recent Medicare cuts at the American Heart Association Scientific Sessions conference in Chicago. 

READ MORE >
ACC President Ed Fry, MD, an interventional and general cardiologist at Ascension St. Vincent Hospital in Indianapolis, Indiana, and chair of the Ascension National Cardiovascular Service Line, says Medicare cuts for 2023 are a tipping point that need to be a call to action across medicine. #AHA22 #ACC
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: ACC president says Medicare cuts should be a call to action across healthcare

Share on Twitter Share on Facebook Share on Linkedin
ACC President Ed Fry, MD, an interventional and general cardiologist at Ascension St. Vincent Hospital in Indianapolis, Indiana, and chair of the Ascension National Cardiovascular Service Line, says Medicare cuts for 2023 are a tipping point that need to be a call to action across medicine. #AHA22 #ACC
American College of Cardiology President Edward Fry, MD, spoke about recent Medicare cuts at the American Heart Association Scientific Sessions conference in Chicago. 
READ MORE >

Drinking coffee may increase the risk of coronary heart disease among men

Among women, on the other hand, drinking coffee may actual reduce the risk of CHD. The full meta-analysis, based on data from 32 different studies, was published in the American Journal of Cardiology.

READ MORE >
old elderly couple coffee drink retired love romance man
Share on Twitter Share on Facebook Share on Linkedin

Drinking coffee may increase the risk of coronary heart disease among men

Share on Twitter Share on Facebook Share on Linkedin
old elderly couple coffee drink retired love romance man
Among women, on the other hand, drinking coffee may actual reduce the risk of CHD. The full meta-analysis, based on data from 32 different studies, was published in the American Journal of Cardiology.
READ MORE >

Diabetes patients are experiencing fewer heart attacks and strokes as patient care continues to evolve

Patients with diabetes faced a much higher risk of a cardiovascular event in 1994 than they did in 2014, according to a new analysis published in JAMA.

READ MORE >
older female patient and doctor
Share on Twitter Share on Facebook Share on Linkedin

Diabetes patients are experiencing fewer heart attacks and strokes as patient care continues to evolve

Share on Twitter Share on Facebook Share on Linkedin
older female patient and doctor
Patients with diabetes faced a much higher risk of a cardiovascular event in 1994 than they did in 2014, according to a new analysis published in JAMA.
READ MORE >

In Case You Missed It

Johnson & Johnson to acquire Abiomed in $16.6B deal

Johnson & Johnson agreed to an upfront payment of $380 per share. Abiomed shareholders can also receive up to an additional $35 per share if certain milestones are met in the years ahead. 

READ MORE >
Money dollar investments
Share on Twitter Share on Facebook Share on Linkedin

Johnson & Johnson to acquire Abiomed in $16.6B deal

Share on Twitter Share on Facebook Share on Linkedin
Money dollar investments
Johnson & Johnson agreed to an upfront payment of $380 per share. Abiomed shareholders can also receive up to an additional $35 per share if certain milestones are met in the years ahead. 
READ MORE >

Interventional cardiologist Deepak L. Bhatt, MD, named new director of Mount Sinai Heart

Bhatt succeeds Valentin Fuster, MD, PhD, who has held the position since 2006 and will now serve in a more advisory role at Mount Sinai Heart.

READ MORE >
Interventional cardiologist Deepak L. Bhatt, MD, has been named the new director of Mount Sinai Heart in New York City. He succeeds Valentin Fuster, MD, PhD, who held the position since 2006 and will now serve in a more advisory role as Mount Sinai Heart’s president.
Share on Twitter Share on Facebook Share on Linkedin

Interventional cardiologist Deepak L. Bhatt, MD, named new director of Mount Sinai Heart

Share on Twitter Share on Facebook Share on Linkedin
Interventional cardiologist Deepak L. Bhatt, MD, has been named the new director of Mount Sinai Heart in New York City. He succeeds Valentin Fuster, MD, PhD, who held the position since 2006 and will now serve in a more advisory role as Mount Sinai Heart’s president.
Bhatt succeeds Valentin Fuster, MD, PhD, who has held the position since 2006 and will now serve in a more advisory role at Mount Sinai Heart.
READ MORE >

In Other News

Q&A: Bicycle Health CMO breaks down telehealth’s role in the opioid crisis

Health Exec caught up with Brian Clear, MD, chief medical officer with Bicycle Health, to learn more about the current state of the opioid overdose crisis and the role of telehealth.

READ MORE >
thumbnail_image.png
Share on Twitter Share on Facebook Share on Linkedin

Q&A: Bicycle Health CMO breaks down telehealth’s role in the opioid crisis

Share on Twitter Share on Facebook Share on Linkedin
thumbnail_image.png
Health Exec caught up with Brian Clear, MD, chief medical officer with Bicycle Health, to learn more about the current state of the opioid overdose crisis and the role of telehealth.
READ MORE >

FDA greenlights intracranial hemorrhage AI

RapidAI has been cleared for U.S. marketing of updated AI-outfitted software that quickly detects or rules out acute brain hemorrhage on unenhanced CT.

READ MORE >
green_light.jpg
Share on Twitter Share on Facebook Share on Linkedin

FDA greenlights intracranial hemorrhage AI

Share on Twitter Share on Facebook Share on Linkedin
green_light.jpg
RapidAI has been cleared for U.S. marketing of updated AI-outfitted software that quickly detects or rules out acute brain hemorrhage on unenhanced CT.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme